As the US and Europe experiences shortages of crucial medicines, Ben Hargreaves looks at how a once thriving generics industry is now struggling, with many companies seeking to exit the space. Generic ...

Faced with the prospect of tariffs on imported medicines threatened by the Trump administration, Indian drugmaker Hikma has said it will spend $1 billion to expand its manufacturing and R&D operations ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...

The Rasmussen Reports daily Presidential Tracking Poll for Tuesday shows that 45% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-three (53%) disapprove. The latest figures ...

Flu season is hitting the United Kingdom earlier than usual and cases are three times as high as last year. ABC News' Dr. Darien Sutton warns it could be a sign of what's to come for the U.S. The flu ...